Cargando…

Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis

BACKGROUND: Although surgery has been widely applied for SPLC therapy, there is still no uniform treatment approach. Whether SPLC and primary lung cancer have similar prognostic characteristics remains controversial. Herein, based on a systematic review and meta-analysis, we aimed to enucleate the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jie, Shen, Zhenghai, Huang, Yunchao, Zhao, Guangqiang, Wang, Wei, Yang, Yantao, Zhou, Chen, Ye, Lianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120155/
https://www.ncbi.nlm.nih.gov/pubmed/37085804
http://dx.doi.org/10.1186/s12893-023-02003-9
_version_ 1785029137046437888
author Zhao, Jie
Shen, Zhenghai
Huang, Yunchao
Zhao, Guangqiang
Wang, Wei
Yang, Yantao
Zhou, Chen
Ye, Lianhua
author_facet Zhao, Jie
Shen, Zhenghai
Huang, Yunchao
Zhao, Guangqiang
Wang, Wei
Yang, Yantao
Zhou, Chen
Ye, Lianhua
author_sort Zhao, Jie
collection PubMed
description BACKGROUND: Although surgery has been widely applied for SPLC therapy, there is still no uniform treatment approach. Whether SPLC and primary lung cancer have similar prognostic characteristics remains controversial. Herein, based on a systematic review and meta-analysis, we aimed to enucleate the influences of diverse surgical strategies and underlying prognostic factors on the prognosis of patients with both the first primary lung cancer and SPLC underwent surgical resection. METHODS: A comprehensive and systematic literature search was implemented in three databases (MEDLINE, EMBASE, and Cochrane), and eligible studies were screened following inclusion and exclusion criteria. Meanwhile, we extracted the hazard ratios (HR) together with 95% confidence intervals (CI) for each prognostic factor, either directly or indirectly, from the enrolled literature. RESULTS: Eleven studies (published between 2000 and 2022) were included in this study, including 1,131 SPLC patients. The overall survival (OS) exhibited no difference between patients with lobectomy and sublobar resection after SPLC (HR: 0.87, 95%CI: 0.62–1.21, P = 0.41). The patients after completion pneumonectomy had a poor prognosis (HR: 1.85, 95% CI: 1.34–2.55, P < 0.01). Poor prognostic factors after SPLC surgery included synchronous SPLC (HR: 3.38, 95%CI: 1.53–7.46, P < 0.01), tumor diameter > 2 cm (HR: 2.44, 95%CI: 1.73–3.44, P < 0.01), solid predominant in CT morphology (HR: 3.08, 95% CI: 1.14–8.33, P = 0.03), lymph node metastasis (HR: 2.79, 95%CI: 1.40–5.56), and smoking (HR: 2.37, 95%CI: 1.08–26.82, P < 0.01). Tumor disease-free interval (DFI), tumor histological type, and gender had no impact on the prognosis of patients received SPLC surgery. CONCLUSIONS: Patients with SPLC, especially those with poor cardiopulmonary function reserve, should be prioritized for sublobar resection for treatment. These patients should also try to avoid completion pneumonectomy. Patients with synchronous SPLC, tumor diameter > 2 cm, solid predominant in CT morphology, lymph node metastasis, and smoking had a poor prognosis. Meanwhile, SPLC has similar prognostic characteristics with single primary lung cancer. However, the study has some limitations and more evidence is warranted to verify the findings.
format Online
Article
Text
id pubmed-10120155
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101201552023-04-22 Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis Zhao, Jie Shen, Zhenghai Huang, Yunchao Zhao, Guangqiang Wang, Wei Yang, Yantao Zhou, Chen Ye, Lianhua BMC Surg Research BACKGROUND: Although surgery has been widely applied for SPLC therapy, there is still no uniform treatment approach. Whether SPLC and primary lung cancer have similar prognostic characteristics remains controversial. Herein, based on a systematic review and meta-analysis, we aimed to enucleate the influences of diverse surgical strategies and underlying prognostic factors on the prognosis of patients with both the first primary lung cancer and SPLC underwent surgical resection. METHODS: A comprehensive and systematic literature search was implemented in three databases (MEDLINE, EMBASE, and Cochrane), and eligible studies were screened following inclusion and exclusion criteria. Meanwhile, we extracted the hazard ratios (HR) together with 95% confidence intervals (CI) for each prognostic factor, either directly or indirectly, from the enrolled literature. RESULTS: Eleven studies (published between 2000 and 2022) were included in this study, including 1,131 SPLC patients. The overall survival (OS) exhibited no difference between patients with lobectomy and sublobar resection after SPLC (HR: 0.87, 95%CI: 0.62–1.21, P = 0.41). The patients after completion pneumonectomy had a poor prognosis (HR: 1.85, 95% CI: 1.34–2.55, P < 0.01). Poor prognostic factors after SPLC surgery included synchronous SPLC (HR: 3.38, 95%CI: 1.53–7.46, P < 0.01), tumor diameter > 2 cm (HR: 2.44, 95%CI: 1.73–3.44, P < 0.01), solid predominant in CT morphology (HR: 3.08, 95% CI: 1.14–8.33, P = 0.03), lymph node metastasis (HR: 2.79, 95%CI: 1.40–5.56), and smoking (HR: 2.37, 95%CI: 1.08–26.82, P < 0.01). Tumor disease-free interval (DFI), tumor histological type, and gender had no impact on the prognosis of patients received SPLC surgery. CONCLUSIONS: Patients with SPLC, especially those with poor cardiopulmonary function reserve, should be prioritized for sublobar resection for treatment. These patients should also try to avoid completion pneumonectomy. Patients with synchronous SPLC, tumor diameter > 2 cm, solid predominant in CT morphology, lymph node metastasis, and smoking had a poor prognosis. Meanwhile, SPLC has similar prognostic characteristics with single primary lung cancer. However, the study has some limitations and more evidence is warranted to verify the findings. BioMed Central 2023-04-21 /pmc/articles/PMC10120155/ /pubmed/37085804 http://dx.doi.org/10.1186/s12893-023-02003-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Jie
Shen, Zhenghai
Huang, Yunchao
Zhao, Guangqiang
Wang, Wei
Yang, Yantao
Zhou, Chen
Ye, Lianhua
Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
title Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
title_full Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
title_fullStr Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
title_full_unstemmed Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
title_short Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
title_sort evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120155/
https://www.ncbi.nlm.nih.gov/pubmed/37085804
http://dx.doi.org/10.1186/s12893-023-02003-9
work_keys_str_mv AT zhaojie evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT shenzhenghai evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT huangyunchao evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT zhaoguangqiang evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT wangwei evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT yangyantao evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT zhouchen evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis
AT yelianhua evaluationofsurgicaloutcomesandprognosticfactorsofsecondprimarylungcancerbasedonasystematicreviewandmetaanalysis